Evidence
Am J Psychiatry. 2023 May 1;180(5):340-347. doi: 10.1176/appi.ajp.20230172.
ABSTRACT
Over the past decade, psychedelic compounds have emerged as potentially transformative therapeutics for a variety of intractable neuropsychiatric conditions. However, historically most of the basic science has utilized these compounds as probes to interrogate various endogenous neurotransmitter systems-mainly the serotonin 5-HT2A receptor. With the renewed interest in utilizing these compounds as therapeutics and the explosion in clinical trials, psychedelics have been purported to treat many neuropsychiatric disorders, including depression, cluster headaches, migraines, anxiety, and obsessive-compulsive disorder. It is therefore imperative to understand the biology and pharmacology behind their therapeutic mechanisms as well as expose any potential pitfalls in their widespread use as treatments. This review covers the latest advances in understanding the biological mechanisms, the newest efforts in drug discovery, and potential pitfalls when it comes to utilizing this class of compounds as emerging therapeutics.
PMID:37122272 | DOI:10.1176/appi.ajp.20230172
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Psychedelics as Transformative Therapeutics
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Integrating Polygenic Scores and Phenotypic Data to Understand Psychiatric Outcomes
- The Influence of Stakeholder Interests on Safety Outcome Reporting in Psychedelic Research and Implications for Science Communication
- Positioning rTMS Within a Sequential Treatment Algorithm of Depression
- Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
- Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
- The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment
- Drug repurposing for cancer
- Drug repurposing for cancer
- Suicide in Black Females
- Genetic Underpinnings of Peer Influence in Adolescents
- Suicide in Black Females: Response to Mattes
- Toward Precision Noninvasive Brain Stimulation
- PTSD, Phobias, Suicide Attempts, and Psychiatric Vulnerabilities
- Decoding Sex Differences in PTSD Heritability: A Comprehensive Twin Study
- The Invisible Children: Is the Glass Half Full or Half Empty?
- The Invisible Children: Is the Glass Half Full or Half Empty?
- Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia
- Natural product pharmacology: the British Journal of Pharmacology perspective
- Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
- Therapeutic drug monitoring in Parkinson's disease
- Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis
- Psychoactive substances for the treatment of neuropsychiatric disorders
- Psychoactive substances for the treatment of neuropsychiatric disorders
- Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent
- Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent
- High-throughput sensitive screening of small molecule modulators of microexon alternative splicing using dual Nano and Firefly luciferase reporters
- Neurobiology and Treatment of Posttraumatic Stress Disorder
- Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation
- Psilocybin for clinical indications: A scoping review
- Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
- Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
- Do classic psychedelics increase the risk of seizures? A scoping review
- Do classic psychedelics increase the risk of seizures? A scoping review
- Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases
- A Comprehensive Review of Low-Intensity Focused Ultrasound Parameters and Applications in Neurologic and Psychiatric Disorders
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
- Transplanting network pharmacology technology into food science research: A comprehensive review on uncovering food-sourced functional factors and their health benefits
- Coffee and Alzheimer's disease
- Antimicrobial activity of compounds identified by artificial intelligence discovery engine targeting enzymes involved in Neisseria gonorrhoeae peptidoglycan metabolism
- Antimicrobial activity of compounds identified by artificial intelligence discovery engine targeting enzymes involved in Neisseria gonorrhoeae peptidoglycan metabolism
- AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1
- Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis
- Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche's Endocannabinoid System Projects
- Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness
- Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease
- Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease
- Curcumin and nano-curcumin applications in psychiatric disorders
- Dietary glycation compounds - implications for human health
- Current state of clinical ultrasound neuromodulation
- Current state of clinical ultrasound neuromodulation
- Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia
- Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor
- How to treat subsyndromal anxiety disorder - practical recommendations for implementation in primary care
- Oxford-Harrington Rare Disease Centre Symposium 2024
- Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money
- Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
- Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
- Apollo Therapeutics and Oxford University enter into drug discovery and development collaboration
- Psychopharmacology Review for Eating Disorders Among Children, Adolescents, and Adults
- A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug Discovery
- Risk of Incident Psychosis and Mania With Prescription Amphetamines
Evidence Blueprint
Psychedelics as Transformative Therapeutics
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychedelics as Transformative Therapeutics
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
- Bedside to bench: the outlook for psychedelic research
- Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
- The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
- Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
- Psychedelics for Alzheimer's Disease-Related Dementia: Unveiling Therapeutic Possibilities and Pathways
- Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
- Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
- Substance Use Disorders Are Psychiatric Disorders
- RNA therapeutics for neurological disease
- Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction
- New Insights Into Psychotic Disorders
- The First Large GWAS Meta-Analysis for Postpartum Depression
- Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities
- Psychedelia: The interplay of music and psychedelics
- Correction to Guintivano et al
- Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?
- Perinatal Mental Health: Advances and Opportunities
- Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity
- Trends in Suicide Among Black Women in the United States, 1999-2020
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- A Mental Health Crisis and Call to Action: Increasing Trends in Suicide Among Black Women in the United States
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Prescription digital therapeutics: An emerging treatment option for negative symptoms in schizophrenia
- Cardiovascular safety of psychedelic medicine: current status and future directions
- Integrating Polygenic Scores and Phenotypic Data to Understand Psychiatric Outcomes
- The Influence of Stakeholder Interests on Safety Outcome Reporting in Psychedelic Research and Implications for Science Communication
- The bodily self from psychosis to psychedelics
- Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
- 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase
- Positioning rTMS Within a Sequential Treatment Algorithm of Depression
- The Developmental Trajectory to Cannabis Use Disorder
- The Developmental Trajectory to Cannabis Use Disorder
- Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
- Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
- The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder
- Pharmacology of platelet immune receptors: mechanisms of activation and development of therapeutics
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- The More Things Change .
- Drug repurposing for cancer
- Drug repurposing for cancer
- Suicide in Black Females
- Network Connection Issues in ADHD
- Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
- Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention
- Advances in Understanding Schizophrenia, ADHD, and ASD
- ADHD and ASD: Time to Split or Lump?
- Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
- Genetic Underpinnings of Peer Influence in Adolescents
- Suicide in Black Females: Response to Mattes
- Multi-target drugs for Alzheimer's disease
- Toward Precision Noninvasive Brain Stimulation
- PTSD, Phobias, Suicide Attempts, and Psychiatric Vulnerabilities
- Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?
- Primordial Origins of RNA Therapeutics